Trial intelligence / Profile preview

VIVA: Volatile or IV Anesthesia for Cancer

NCT06017141Phase 2Recruiting

Sponsor
University of Kansas Medical Center
Start
May 2023
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of propofol injection (veterinary) in colon adenocarcinoma, sponsored by University of Kansas Medical Center. Started May 2023; status: recruiting.

02

Drugs

propofol injection (veterinary)
03

Conditions

colon adenocarcinoma

Beyond the preview

Go deeper on NCT06017141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06017141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call